Table 4.

Specificity or sensitivity of NNMT and 3-marker combination in control individual and kidney tumors according to its pathologic tumor stages

Sensitivity (%)
Specificity (%)pT stage
ControlStage Ia/IbStage IIStage IIIa/IIIbStage VI
NNMT at cut-off > 147 pg/mL83.4 (29/175)92 (54/59)100 (13/13)100 (29/29)100 (2/2)
NNMT, LCP1, NM23A Score at cut-off > 190.9 (16/175)95 (56/59)92 (12/13)97 (28/29)100 (2/2)